Benitec Biopharma logo

Benitec Biopharma

BNTC | NASDAQ
Chart Builder DCF Calculator
$8.54
-$0.50 (-5.53%)
At close: Nov 16, 2026, 4:00 PM ET
$8.54
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:10 PM ET
-5.53%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
22.8
-1.0 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #970/1021 (Top 95%)

Key Statistics

Market Data

Market Cap $422.62M
1D Range
8.49 9.30
52W Range
8.11 14.08

Valuation (TTM)

PE -8.29
PB 2.49
EV/EBITDA -4.58

Valuation (NTM)

Forward PE N/A
Forward PEG -0.36
Price Target $15.50
Loading financial charts...

Profile

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA int...

Sector Healthcare
Industry Biotechnology
Employees 24
IPO Date Jun 24, 2014
Website benitec.com
Fiscal Year July - June

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$17.00
Upside
+99.06%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.